Journal
CURRENT OPINION IN GENETICS & DEVELOPMENT
Volume 17, Issue 1, Pages 66-70Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2006.12.003
Keywords
-
Categories
Funding
- NCI NIH HHS [CA82577, CA34936] Funding Source: Medline
Ask authors/readers for more resources
Tumors associated with p53 usually contain missense mutations in the p53 tumor suppressor gene rather than deletions of p53, suggesting a growth advantage for cells with missense mutations. The oncogenic roles of p53 mutants have been examined extensively in cell lines. Mouse models that inherit p53 mutations expressed at physiological levels have now been generated to examine the activities of mutant p53 upon tumorigenesis in vivo. Mice with p53 mutations develop tumor spectrums and metastatic phenotypes different from those of mice with a p53-null allele. Embryo fibroblasts with mutant p53 also show increased proliferative and transformation properties. One mechanism for this gain-of-function potential is the inhibition of function of the p53 family members p63 and p73.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available